Your browser doesn't support javascript.
loading
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Gillison, Maura L; Trotti, Andy M; Harris, Jonathan; Eisbruch, Avraham; Harari, Paul M; Adelstein, David J; Jordan, Richard C K; Zhao, Weiqiang; Sturgis, Erich M; Burtness, Barbara; Ridge, John A; Ringash, Jolie; Galvin, James; Yao, Min; Koyfman, Shlomo A; Blakaj, Dukagjin M; Razaq, Mohammed A; Colevas, A Dimitrios; Beitler, Jonathan J; Jones, Christopher U; Dunlap, Neal E; Seaward, Samantha A; Spencer, Sharon; Galloway, Thomas J; Phan, Jack; Dignam, James J; Le, Quynh Thu.
Afiliación
  • Gillison ML; Department of Thoracic Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mgillison@mdanderson.org.
  • Trotti AM; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Harris J; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA.
  • Eisbruch A; Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
  • Harari PM; Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
  • Adelstein DJ; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Jordan RCK; Department of Orofacial Sciences, University of California San Fransisco, San Francisco, CA, USA; Department of Pathology, University of California San Fransisco, San Francisco, CA, USA.
  • Zhao W; Division of Molecular Pathology, Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Division of Hematopathology, Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA; James Molecular Laboratory, Columbus, OH, USA.
  • Sturgis EM; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.
  • Burtness B; Department of Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Ridge JA; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ringash J; Department of Radiation Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, ON, Canada.
  • Galvin J; Imaging and Radiation Oncology Core Group, Philadelphia, PA, USA.
  • Yao M; Department of Radiation Oncology, Case Western Reserve/University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • Koyfman SA; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Blakaj DM; Department of Radiation Oncology, The Ohio State University, Columbus, OH, USA.
  • Razaq MA; Department of Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Colevas AD; Department of Medicine (Oncology), Stanford University, Stanford, CA, USA.
  • Beitler JJ; Department of Radiation Oncology, Emory University, Atlanta, GA, USA.
  • Jones CU; Department of Radiation Oncology, Sutter Cancer Research Consortium, Novato, CA, USA.
  • Dunlap NE; Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
  • Seaward SA; Department of Radiation Oncology, Kaiser Permanente, Oakland, CA, USA.
  • Spencer S; Department of Radiation Oncology, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.
  • Galloway TJ; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Phan J; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Dignam JJ; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA.
  • Le QT; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Lancet ; 393(10166): 40-50, 2019 01 05.
Article en En | MEDLINE | ID: mdl-30449625
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Orofaríngeas / Cisplatino / Cetuximab / Carcinoma de Células Escamosas de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Orofaríngeas / Cisplatino / Cetuximab / Carcinoma de Células Escamosas de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2019 Tipo del documento: Article